Portland, Oregon Area, OR United States
Group Leader, Molecular Biology, Oregon Health & Science University & Knight Cancer Institute
Medical / Health Care / Pharmaceuticals
I study rare genetic variants to understand fundamental biology and de-risk drug development. We use biochemical and novel computational methods to evaluate genetic variants in the Fanconi anemia/breast cancer pathway, a complex multi-gene network that influences development, cancer susceptibility and bone marrow failure in rare disease patients and perhaps within the general population.